Finance

Beta
Lists
MLYS:NASDAQ
Mineralys Therapeutics Inc
$24.05
+6.89%
(+1.55) 1D
Jun 9, 3:31:59 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLYS...
Open
$22.90
High
$24.00
Low
$22.86
Mkt. cap
2.11B
Avg. vol.
1.59M
Volume
1.86M
52-wk high
$47.65
52-wk low
$12.59
EPS
-$2.06
Beta
0.57
Shares outstanding
82.50M
No. of employees
76
Open
$22.90
High
$24.00
Low
$22.86
Mkt. cap
2.11B
Avg. vol.
1.59M
Volume
1.86M
52-wk high
$47.65
52-wk low
$12.59
EPS
-$2.06
Beta
0.57
Shares outstanding
82.50M
No. of employees
76
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to MLYS in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for MLYS in the last 3 months.
Highest
Current $24.05
$56.00 (+132.85%)
Average
$51.17 (+112.77%)
Lowest
$42.00 (+74.64%)
News stories
From sources across the web
About Mineralys Therapeutics Inc
CEO-
Employees76
Founded2019
Headquarters-
SectorBiotechnology
Websitemineralystx.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.47 / -$0.44
-6.82%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
38.28M
31.45M
24.40M
24.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.47M
9.68M
13.88M
20.98M
Operating expense
46.75M
41.13M
38.28M
45.34M
Total operating expenses
46.75M
41.13M
38.28M
45.34M
Operating income
-46.75M
-41.13M
-38.28M
-45.34M
Other non operating income
-2.00K
4.00K
1.00K
5.00K
EBT including unusual items
-43.27M
-36.93M
-32.23M
-39.34M
EBT excluding unusual items
-43.27M
-36.93M
-32.23M
-39.34M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.27M
-36.93M
-32.23M
-39.34M
Net profit margin
-
-
-
-
Earnings per share
-0.66
-0.52
-0.40
-0.47
Interest and investment income
3.47M
4.20M
6.04M
6.00M
Interest expense
-
-
-
-
Net interest expenses
3.47M
4.20M
6.04M
6.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.73M
-41.12M
-38.27M
-45.33M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer